Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.122 (Delta)ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21969.5Japan
AY.122 (Delta)ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
AY.122 (Delta)SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-20677.6Japan
B.1.1.7 (Alpha)ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
B.1.1.7 (Alpha)ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
B.1.1.7 (Alpha)NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-22126.5Thailand
B.1.1.7 (Alpha)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
B.1.1.7 (Alpha)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.7 (Alpha)ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21969.5Japan
B.1.1.7 (Alpha)ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
B.1.1.7 (Alpha)SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-20677.6Japan
P.1 (Gamma)ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
P.1 (Gamma)ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
P.1 (Gamma)NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-22126.5Thailand
P.1 (Gamma)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
P.1 (Gamma)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
P.1 (Gamma)ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-18356.8Japan
P.1 (Gamma)ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
P.1 (Gamma)SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-20677.6Japan
AY.120.1 (Delta)ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
AY.120.1 (Delta)ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
AY.120.1 (Delta)NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-22126.5Thailand
AY.120.1 (Delta)NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
AY.120.1 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
AY.120.1 (Delta)ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-17147.9Japan
AY.120.1 (Delta)ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
AY.120.1 (Delta)SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-20677.6Japan
AY.119.2 (Delta)ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
AY.119.2 (Delta)ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
GS.8ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
GS.8ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
GS.8NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
GS.8NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GS.8NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
GS.8ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21969.5Japan
GS.8ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
GS.8SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-20677.6Japan
GE.1.4ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
GE.1.4ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
GE.1.4NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
GE.1.4NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GE.1.4NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
GE.1.4ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21969.5Japan
GE.1.4ORF1abNIID WH-1 Seq F519R840GACATAGCGAGTGTATGCC1952.63823805R-20165.2Japan
GE.1.4SNIID WH-1 Seq F24383R24865CAAAGACACCTTCACGAGG1952.632484824830R-20677.6Japan
XBB.1.5.93ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
XBB.1.5.93ORF1abCN-CDC-ORF1abACGATTGTGCATCAGCTGA1947.371346013442R-20306.2China
XBB.1.5.93NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
XBB.1.5.93NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.5.93NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used